RxDoctor Payments DataLook up a doctor →

Byron Lee, MD

Clinical Cardiac Electrophysiology · Palo Alto, CANPI 1700835584

Payments from drug & device makers

$861,996in general payments, 2019–2025

Across 279 payments — averaging $3089.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Research Incorporated$378K
  • Medtronic$196K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$171K
  • Braemar Manufacturing, LLC$33K
  • Boston Scientific$31K
  • Cook Incorporated$23K
  • plus $30K from 14 others
$3,213in research payments, 2019–2025

Across 2 payments — averaging $1606.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$3K

What the payments were for

  • Consulting fees$39,50015%
  • Speaking & faculty fees$199,13575%
  • Travel & lodging$19,5737%
  • Food & beverage$8,8143%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$861,996 in reported general payments places this provider in the 90th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California

Medicare billing

Part B allowed, 2024
$102,843
Medicare patients
804
Services billed
1,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$48,841
Propafenone Hcl ErPropafenone Hcl16$4,610
Flecainide Acetate31$1,695
Amiodarone Hcl18$1,198
Metoprolol Succinate60$806
Cephalexin14$57

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →